King Abdullah University Hospital

kauh.jo

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

49

Active

23

Phase 3

1

Total enrollment

4,299

Pipeline matrix

Showing 12 of 12 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Salbutamol1
Intraoperative ketamine1
induced bleeding1
plasma rich fibrin1
Conventional nanohybrid multishade composite and hydrogen peroxide 40% in-Office Tooth Whitening System1
Single shade nanohybrid composite and hydrogen peroxide 40% in-Office Tooth Whitening System1
Pure Green Tea Mouthwash1
Listerine Total Care Mouthwash1
Listerine Green Tea Mouthwash1
Conventional nanohybrid multishade composite1
Single shade nanohybrid composite1
Application of NBF gel after soft tissue graft surgery1

Next readouts

  • 2025-12-01
  • 2026-05-01
  • 2026-05-01
  • 2026-06-30
  • 2026-10
  • 2026-12
  • 2026-12

Top conditions

  • Dental Plaque3
  • Gingival Bleeding3
  • Gingivitis3
  • Pain Management2
  • Composite Resins2
  • Diabete Mellitus2
  • Molar Incisor Hypomineralization2
  • Dental Caries2

Frequently asked questions about King Abdullah University Hospital

How many clinical trials does King Abdullah University Hospital have on ClinicalTrials.gov?
King Abdullah University Hospital is listed as the lead sponsor on 49 clinical trials in ClinicalTrials.gov, 23 of which are currently active (recruiting, enrolling, or ongoing).
How many of King Abdullah University Hospital's trials are in Phase 3?
1 of King Abdullah University Hospital's trials are in Phase 3, spread across 12 active drug programs.
What therapeutic areas does King Abdullah University Hospital focus on?
King Abdullah University Hospital's most-studied conditions on ClinicalTrials.gov are Dental Plaque, Gingival Bleeding, Gingivitis, Pain Management, Composite Resins.
When are King Abdullah University Hospital's next clinical trial readouts?
King Abdullah University Hospital has 7 upcoming primary-completion readouts tracked here; the soonest is “Outcome of Pulp Revascularization of Necrotic Mature Permanent Teeth Using Platelet-rich Fibrin”, expected around 2025-12-01.